Recent News

The latest news from the governments, medical industry and top online sources.

Fostering regulatory collaboration to improve access to mpox…

International regulators have published a report highlighting their considerations on the development, clinical trials and availability of vaccines and therapeutics for mpox. The report presents the outcomes of a workshop that was organised by EMA under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). In August 2024, the World Health Organisation (WHO) declared mpox […]

Valneva Scotland announces year-long support for local cance…

The company’s workforce will volunteer and fundraise for Team Jak throughout the year Valneva Scotland has partnered with Team Jak, a West Lothian-headquartered charity focused on supporting children and young people with cancer. The Livingston-based vaccine producer will provide year-long support to Team Jak, which offers emotional, social and practical support to patients aged zero […]

EMA Management Board: highlights of October 2024 meeting

Election of new vice-chair The Management Board elected Rui Santos Ivo, President of the Portuguese National Authority of Medicines and Healthcare Products (INFARMED), as its new vice-chair, with a three-year mandate from October 2024. Professor Ivo is an Associate Professor of Medicines Regulation at the University of Lisbon Faculty of Pharmacy and holds a post […]

European Commission approves Yuvanci for pulmonary arterial …

Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe The European Commission has approved Yuvanci (macitentan 10 mg and tadalafil 40 mg), a single tablet combination therapy (STCT) for the long-term treatment of pulmonary arterial hypertension (PAH) in adult patients. This approval marks a significant milestone as Yuvanci becomes the only […]

New chair elected for EMA’s Orphan Medicinal Products Commit…

Tim Leest succeeds Dr Violeta Stoyanova-Beninska as a chair, following her completion of the maximum two three-year terms allowed for COMP chairs. COMP is responsible for evaluating applications for orphan designation. This designation is for medicines to be developed for the diagnosis, prevention or treatment of rare diseases that are life-threatening or very serious. COMP […]

Phase 2 PREDICT-ILD imaging study commences in interstitial …

Molecular imaging agent 99mTc-maraciclatide to aid in disease prognostication Serac Healthcare, a clinical radiopharmaceutical company, and the University of Exeter have announced the commencement of a Phase II study involving a novel molecular SPECT imaging agent, 99mTc-maraciclatide. This study, named ‘PRospective Evaluation of Interstitial Lung Disease progression with quantitative CT (PREDICT-ILD)’, has successfully scanned its […]

EMA is closed on Assumption Day, 15 August

Outside of working hours and on public holidays, it is possible to call the product emergency hotline on +31(0)88 781 7600.Please note that this is an emergency number that should… Source/Attributions: This news post was originally posted at www.ema.europa.eu

Theramex’s Eladynos recommended by NICE for post-menopausal …

Osteoporosis currently affects 3.8 million people in the UK, particularly impacting older women after menopause Theramex’s Eladynos (abaloparatide) has been recommended by the National Institute for Health Care and Research (NICE) for treating bone disease after menopause. More than 14,000 people in the UK seek treatment for osteoporosis after menopause, and these patients will benefit […]

New pilot programme to support orphan medical devices

EMA has launched a pilot programme for expert panels to support the development and assessment of orphan medical devices in the European Union (EU). The pilot programme offers free advice from the medical device expert panels to selected manufacturers and notified bodies on the orphan device status and the data needed for their clinical evaluation. […]

Study reveals new insights into ‘gene misbehaviour’ in healt…

The findings could support investigations into human genetics and various complex diseases Researchers from the Wellcome Sanger Institute, the University of Cambridge and AstraZeneca have revealed new insights into widespread ‘gene misbehaviour’ in healthy populations. The study published in the American Journal of Human Genetics reveals how the human genetic code operates, which could support […]